Skip to main content
Clinical Trials/JPRN-UMIN000021138
JPRN-UMIN000021138Recruiting未知

Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery. - Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in atrial fibrillation after cardiac surgery.

ihon University school of medicine0 sites150 target enrollmentStarted: February 23, 2016Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
150

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 90years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • past of arrhythmia cardiogenic shock NYHA class IV congestive heart failure despite treatment sinus bradycardia at rest (<50/min) second -or third-degree AV block clinical hypothyroidism or hyperthyroidism Doctor's decision not to register to this regimen

Investigators

Sponsor
ihon University school of medicine

Similar Trials